Massmedica Investor Relations

Massmedica S.A. engages in the distribution of implants and other medical materials used in the treatment of musculoskeletal system diseases and regenerative medicines in Poland. It offers products in the field of reconstructive, regenerative, anti-aging, and aesthetic medicine. The company’s products include dietary supplements, skin care cosmetics, sun protection creams, tools for home treatments, and intra-articular injections for regeneration of the knee joints. It also provides reconstructive products, such as hip endoprostheses, 3D endoportesis, and synthetic tendon ligaments; AdipSculpt, a fat graft collection and preparation kit for controlling vacuum during liposuction; and Ejal40, a locally acting non-surgical medical treatment that delivers regenerating or nourishing nutrients directly to the dermis. The company offers its products to public and private hospitals. Massmedica S.A. was founded in 2011 and is headquartered in Warsaw, Poland.

Read Less